DS-1103A drug page Clinical trials

Trials with DS-1103A

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
4Countries
108Planned patients

Showing 1–1 of 1

A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
Recruiting Phase 1 108 patients NCT05765851

This study will evaluate the safety and efficacy of DS-1103a combination therapy in participants with advanced solid tumors.

United States, Canada, France, Spain May 2023 – May 2030 Interventional
Combined with: Trastuzumab deruxtecan

Where the recruiting trials are